Characteristics | ERAS (n = 60) | Control (n = 60) | p |
---|---|---|---|
Age (year, mean ± s.d.) | 54.1 ± 10.6 | 52.4 ± 10.3 | 0.357 |
Sex (male/female) | 24/36 | 28/32 | 0.461 |
BMI (kg/m2) | 22.5 ± 3.3 | 22.8 ± 3.1 | 0.609 |
Education level (year) | 10.6 ± 2.8 | 10.2 ± 2.6 | 0.419 |
ASA (II/III) | 31/29 | 34/26 | 0.514 |
Comorbidities | |||
Hypertension (yes/no) | 33/27 | 26/34 | 0.201 |
Diabetes (yes/no) | 10/50 | 12/48 | 0.637 |
COPD (yes/no) | 18/42 | 21/39 | 0.559 |
PaO2 (mm Hg, mean ± s.d.) | 87.9 ± 6.8 | 87.4 ± 6.4 | 0.679 |
PaCO2 (mm Hg, mean ± s.d.) | 40.4 ± 2.5 | 40.2 ± 2.3 | 0.649 |
FEV1 (%, mean ± s.d.) | 92.4 ± 16.1 | 93.1 ± 15.8 | 0.811 |
DLCO (%, mean ± s.d.) | 81.2 ± 22.7 | 80.6 ± 23.0 | 0.886 |
Pathologic stage | 0.132 | ||
IIA | 22 | 28 | |
IIB | 11 | 16 | |
IIIA | 25 | 16 | |
IIIB | 2 | 0 | |
Resection (lobectomy/segmentectomy) | 35/25 | 37/23 | 0.709 |